R.L. Whiting
-
- Neuropeptides and Animal Physiology 22
- Neuroscience and Neuropharmacology Research 20
- Neurotransmitter Receptor Influence on Behavior 11
- Molecular Biology top 5%
- Receptor Mechanisms and Signaling 51
- Ion channel regulation and function 32
- Physiology top 5%
- Nitric Oxide and Endothelin Effects 8
- Gastroenterology top 5%
- Gastrointestinal motility and disorders 5
-
- Eicosanoids and Hypertension Pharmacology 5
- Co-authors
- Richard M. EglenAnton D. MichelDana N. LouryA.D. MichelEric StefanichNajam A. SharifLiron WalshRobin D. Clark
- Journals
- British Journal of Pharmacology (27 papers)European Journal of Pharmacology (9 papers)Neurochemical Research (6 papers)
- Partner nations
- PolandUnited StatesUnited Kingdom
In The Last Decade
R.L. Whiting
115 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 125
- Cellular and Molecular Neuroscience 1.5k
- Molecular Biology 2.0k
- Physiology 737
- Endocrine and Autonomic Systems 139
- Gastroenterology 110
Countries citing papers authored by R.L. Whiting
This map shows the geographic impact of R.L. Whiting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.L. Whiting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.L. Whiting more than expected).
Fields of papers citing papers by R.L. Whiting
This network shows the impact of papers produced by R.L. Whiting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.L. Whiting. The network helps show where R.L. Whiting may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R.L. Whiting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis | 2022 | 5 |
| 2 | 1995 | 51 | |
| 3 | 1995 | 5 | |
| 4 | 1993 | 11 | |
| 5 | 1992 | 28 | |
| 6 | 1992 | 17 | |
| 7 | 1991 | 9 | |
| 8 | 1990 | 108 | |
| 9 | 1990 | 32 | |
| 10 | 1990 | 33 | |
| 11 | 1990 | 42 | |
| 12 | 1989 | 8 | |
| 13 | 1989 | 54 | |
| 14 | 1989 | 8 | |
| 15 | 1989 | 28 | |
| 16 | 1989 | 4 | |
| 17 | 1989 | 107 | |
| 18 | 1988 | 47 | |
| 19 | 1988 | 50 | |
| 20 | d10遷移金属錯体における結合 IV いくつかのジハロ金(I)酸錯体の赤外,RamanおよびN.Q.R.による研究 | 1976 | 14 |
About R.L. Whiting
R.L. Whiting is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Gastroenterology, having authored 117 papers that have together received 3.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (51 papers), Ion channel regulation and function (32 papers), Neuropeptides and Animal Physiology (22 papers), Neuroscience and Neuropharmacology Research (20 papers), Neurotransmitter Receptor Influence on Behavior (11 papers), Nitric Oxide and Endothelin Effects (8 papers), Gastrointestinal motility and disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.5k citations), Molecular Biology (2.0k citations) and Physiology (737 citations). R.L. Whiting has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Richard M. Eglen, Anton D. Michel, Dana N. Loury, A.D. Michel, Eric Stefanich, Najam A. Sharif, Liron Walsh, Robin D. Clark, William W. Montgomery and Ronald G. Kay. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology, Neurochemical Research, Journal of Pharmacology and Experimental Therapeutics and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.